Sentinel Lymph Node Biopsy: Clinical Trials

8 trials of Sentinel Lymph Node Biopsy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 28Completed 8
Phase 11Completed 1
Phase 31Completed 1

Follow Sentinel Lymph Node Biopsy: new trials by email Literature Review of Sentinel Lymph Node Biopsy trials Research Report on Sentinel Lymph Node Biopsy

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer
Axillary Lymph Node Dissection, Enzalutamide, Laboratory Biomarker Analysis - Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7
Phase 2CompletedM.D. Anderson Cancer Center242016-09-222026-05-12
A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers
Sentinel Lymph Node Biopsy, indocyanine green (ICG) - Pediatric Patients With Solid Tumors
Phase 2 / Phase 3CompletedMemorial Sloan Kettering Cancer Center62016-09-132022-10-05
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer
systemic chemotherapy, axillary lymph node dissection, neoadjuvant therapy - Breast Cancer
Phase 2CompletedAlliance for Clinical Trials in Oncology7562009-07-012023-04-27
Lymph Node Mapping in Finding Metastatic Disease in Patients With Sebaceous Gland Cancer of the Eyelid
Lymph Node Mapping, Sentinel Lymph Node Biopsy, Technetium Tc-99m Sulfur Colloid - Eyelid Sebaceous Gland Carcinoma
Phase 2CompletedM.D. Anderson Cancer Center202009-02-252025-07-04
Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
fludeoxyglucose F 18, positron emission tomography, computed tomography - Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)3842007-09-012019-07-23
Magnetic Resonance Imaging Using Ferumoxtran-10 in Finding Metastases to the Axillary Lymph Nodes in Patients With Breast Cancer
ferumoxtran-10, magnetic resonance imaging, sentinel lymph node biopsy - Breast Cancer
Phase 2CompletedVirginia Commonwealth University32005-09-012010-05-03
Gefitinib in Treating Patients With Cervical Cancer
gefitinib, immunohistochemistry staining method, surface-enhanced laser desorption/ionization-time of flight mass spectrometry - Cervical Cancer, Fallopian Tube Cancer
Phase 2CompletedNational Cancer Institute (NCI)2002-10-012013-06-20
Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation
Sentinel Node Biopsy - Breast Cancer
Phase 2CompletedUniversity of Arkansas6991998-12-012016-10-27

Conditions studied

Breast Neoplasms (4)  ·  Uterine Cervical Neoplasms (2)  ·  Breast Neoplasms, Male (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Endometrial Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Triple Negative Breast Neoplasms (1)

Sponsors

M.D. Anderson Cancer Center (2)  ·  National Cancer Institute (NCI) (2)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  University of Arkansas (1)  ·  Virginia Commonwealth University (1)

Countries

United States (8)  ·  Canada (1)  ·  Japan (1)  ·  South Korea (1)

Top investigators

Bita M Esmaeli (1)  ·  Clinton Yam (1)  ·  Judy Boughey, MD (1)  ·  Karen A. Kurdziel, MD (1)  ·  Mostafa Atri (1)  ·  Todd Heaton, MD (1)  ·  V. Suzanne Klimberg, MD (1)  ·  Virginia Kwitkowski, MS, RN, CS, CRNP (1)

Results publications

PMID 15166963, PMID 17330838, PMID 18777194, PMID 21918427, PMID 24101169, PMID 25646192, PMID 25664534, PMID 28657941, PMID 29980907

NIH funding

P30CA016059 (1), U10CA027469 (1), U10CA180868 (1)